Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 251

1.

Distinct leukemia phenotypes in transgenic mice and different corepressor interactions generated by promyelocytic leukemia variant fusion genes PLZF-RARalpha and NPM-RARalpha.

Cheng GX, Zhu XH, Men XQ, Wang L, Huang QH, Jin XL, Xiong SM, Zhu J, Guo WM, Chen JQ, Xu SF, So E, Chan LC, Waxman S, Zelent A, Chen GQ, Dong S, Liu JX, Chen SJ.

Proc Natl Acad Sci U S A. 1999 May 25;96(11):6318-23.

2.

Leukemia with distinct phenotypes in transgenic mice expressing PML/RAR alpha, PLZF/RAR alpha or NPM/RAR alpha.

Rego EM, Ruggero D, Tribioli C, Cattoretti G, Kogan S, Redner RL, Pandolfi PP.

Oncogene. 2006 Mar 23;25(13):1974-9.

PMID:
16331271
4.

Deregulation of NPM and PLZF in a variant t(5;17) case of acute promyelocytic leukemia.

Hummel JL, Wells RA, Dubé ID, Licht JD, Kamel-Reid S.

Oncogene. 1999 Jan 21;18(3):633-41.

5.

Distinct interactions of PML-RARalpha and PLZF-RARalpha with co-repressors determine differential responses to RA in APL.

He LZ, Guidez F, Tribioli C, Peruzzi D, Ruthardt M, Zelent A, Pandolfi PP.

Nat Genet. 1998 Feb;18(2):126-35.

PMID:
9462740
6.

[hCG-PLZF-RARalpha/hCG-RARalpha-PLZF transgenic mice developing into leukemia].

Chen LJ, Dong Y, Chen SY, Zhang L, Zhou GB, Chen B, Wang L, Chen Z, Chen SJ.

Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2005 Dec;13(6):924-31. Chinese.

PMID:
16403252
8.

Amino-terminal protein-protein interaction motif (POZ-domain) is responsible for activities of the promyelocytic leukemia zinc finger-retinoic acid receptor-alpha fusion protein.

Dong S, Zhu J, Reid A, Strutt P, Guidez F, Zhong HJ, Wang ZY, Licht J, Waxman S, Chomienne C, Chen Z, Zelent A, Chen SJ.

Proc Natl Acad Sci U S A. 1996 Apr 16;93(8):3624-9.

9.

Fusion proteins of the retinoic acid receptor-alpha recruit histone deacetylase in promyelocytic leukaemia.

Grignani F, De Matteis S, Nervi C, Tomassoni L, Gelmetti V, Cioce M, Fanelli M, Ruthardt M, Ferrara FF, Zamir I, Seiser C, Grignani F, Lazar MA, Minucci S, Pelicci PG.

Nature. 1998 Feb 19;391(6669):815-8.

PMID:
9486655
10.

Acute leukemia with promyelocytic features in PML/RARalpha transgenic mice.

He LZ, Tribioli C, Rivi R, Peruzzi D, Pelicci PG, Soares V, Cattoretti G, Pandolfi PP.

Proc Natl Acad Sci U S A. 1997 May 13;94(10):5302-7.

11.

Two critical hits for promyelocytic leukemia.

He LZ, Bhaumik M, Tribioli C, Rego EM, Ivins S, Zelent A, Pandolfi PP.

Mol Cell. 2000 Nov;6(5):1131-41.

12.
15.

The theory of APL.

Piazza F, Gurrieri C, Pandolfi PP.

Oncogene. 2001 Oct 29;20(49):7216-22. Review.

16.

The molecular biology of acute promyelocytic leukemia.

Slack JL, Gallagher RE.

Cancer Treat Res. 1999;99:75-124. Review.

PMID:
9891864
17.

Translocations of the RARalpha gene in acute promyelocytic leukemia.

Zelent A, Guidez F, Melnick A, Waxman S, Licht JD.

Oncogene. 2001 Oct 29;20(49):7186-203. Review.

18.

8-CPT-cAMP/all-trans retinoic acid targets t(11;17) acute promyelocytic leukemia through enhanced cell differentiation and PLZF/RARα degradation.

Jiao B, Ren ZH, Liu P, Chen LJ, Shi JY, Dong Y, Ablain J, Shi L, Gao L, Hu JP, Ren RB, de Thé H, Chen Z, Chen SJ.

Proc Natl Acad Sci U S A. 2013 Feb 26;110(9):3495-500. doi: 10.1073/pnas.1222863110. Epub 2013 Feb 4.

20.

Supplemental Content

Support Center